Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial
NCT02086006
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
DESolve Novolimus Eluting Bioresorbable Coronary Scaffold
Sponsor
Elixir Medical Corporation